148 related articles for article (PubMed ID: 11776598)
21. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
22. The frequency of cytochrome P450 2E1 polymorphisms in Black South Africans.
Chelule PK; Pegoraro RJ; Gqaleni N; Dutton MF
Dis Markers; 2006; 22(5-6):351-4. PubMed ID: 17264406
[TBL] [Abstract][Full Text] [Related]
23. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
Ulusoy G; Arinç E; Adali O
Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province.
Cai L; Yu SZ; Zhan ZF
World J Gastroenterol; 2001 Dec; 7(6):792-5. PubMed ID: 11854903
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of prostate cancer susceptibility with genetic polymorphism of cytochrome P450 2E1, smoking and drinking: a case-control study in the population of Nanjing area].
Yang J; Gu M; Song NH; Feng NH; Hua LX; Ju XB; Sui YG; Wang XR; Wu HF
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):7-11. PubMed ID: 19288740
[TBL] [Abstract][Full Text] [Related]
26. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
27. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
[TBL] [Abstract][Full Text] [Related]
28. CYP2E1 RsaI and 96-bp insertion genetic polymorphisms associated with risk for colorectal cancer.
Silva TD; Felipe AV; Pimenta CA; Barão K; Forones NM
Genet Mol Res; 2012 Sep; 11(3):3138-45. PubMed ID: 23007992
[TBL] [Abstract][Full Text] [Related]
29. Combined genetic polymorphism and risk for development of lung cancer.
el-Zein R; Zwischenberger JB; Wood TG; Abdel-Rahman SZ; Brekelbaum C; Au WW
Mutat Res; 1997 Nov; 381(2):189-200. PubMed ID: 9434875
[TBL] [Abstract][Full Text] [Related]
30. An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a Chinese population.
Chao YC; Young TH; Chang WK; Tang HS; Hsu CT
Hepatology; 1995 Nov; 22(5):1409-14. PubMed ID: 7590656
[TBL] [Abstract][Full Text] [Related]
31. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
[TBL] [Abstract][Full Text] [Related]
32. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.
Niu Y; Hu Y; Wu M; Jiang F; Shen M; Tang C; Chen N
Mol Biol Rep; 2012 Jan; 39(1):607-12. PubMed ID: 21553050
[TBL] [Abstract][Full Text] [Related]
33. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
J Cell Mol Med; 2015 Sep; 19(9):2136-42. PubMed ID: 25945422
[TBL] [Abstract][Full Text] [Related]
34. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.
Su XL; Bin B; Cui HW; Ran MR
Chin J Cancer Res; 2011 Jun; 23(2):107-11. PubMed ID: 23483202
[TBL] [Abstract][Full Text] [Related]
36. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
[TBL] [Abstract][Full Text] [Related]
37. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.
Liu C; Wang H; Pan C; Shen J; Liang Y
Tumour Biol; 2012 Aug; 33(4):979-84. PubMed ID: 22249978
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users.
Sikdar N; Mahmud SA; Paul RR; Roy B
Cancer Lett; 2003 May; 195(1):33-42. PubMed ID: 12767509
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
[TBL] [Abstract][Full Text] [Related]
40. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
